US Senator Steve Daines to lead visit to China before May summit, SCMP reports

A bipartisan five-member U.S. delegation led by Senator Steve Daines is reportedly set to visit China starting May 1, with stops in Shanghai and Beijing ahead of a scheduled Trump-Xi meeting on May 14-15. The trip, postponed because of the Iran war, underscores ongoing geopolitical and trade-related tensions but contains no direct policy announcement or market-moving detail. Reuters said it could not immediately verify the report.

Analysis

This is less about the optics of a delegation and more about the market using China policy as a proxy for the next phase of U.S.-China bargaining: tariffs, export controls, and procurement access. A high-level bipartisan visit paired with an eventual presidential trip raises the odds of a short-lived de-escalation headline cycle, which tends to compress risk premia for U.S.-listed China-exposed AI/hardware names before any actual policy is resolved.

For SMCI, the second-order issue is not direct China demand so much as supply-chain normalization and inventory repricing. If talks reduce the probability of new semiconductor or server-component restrictions, the multiple can re-rate quickly on “less bad” policy even without improving end-demand; conversely, any leak that the visit is cosmetic would hit the most levered AI infrastructure names first because they trade on policy optionality, not just fundamentals.

APP is a different expression of the same theme: it has less direct China exposure, but it is a high-beta AI beneficiary that often gets pulled into the same factor basket when investors rotate into 'AI winners' after geopolitical headlines. The contrarian read is that this news is probably too small to justify a directional macro position on its own, so the cleaner trade is to express a relative view: long U.S. AI compute beneficiaries versus a broad China-sensitive basket, with the catalyst window measured in days to weeks rather than quarters.

The key risk is that markets overprice a diplomatic thaw before there is any concrete concession on export controls or tariffs. If the meeting schedule slips, or if officials immediately walk back expectations, the rally in policy-sensitive semis and server names should fade quickly; that makes call spreads preferable to outright longs, since the upside is headline-driven while the downside is a reversal to prior positioning.

Key Decisions for Investors

• Buy SMCI calls or call spreads into any dip over the next 1-2 weeks; the trade works if headlines imply reduced U.S.-China frictions, with a tight invalidation if the visit is downgraded or postponed again.
• Relative-value trade: long SMCI / short a China-exposed hardware basket over the next 2-6 weeks; this captures policy de-risking without relying on a broad market rally.
• Add a smaller tactical long in APP on a 1-2 week horizon only as a factor-catchup trade; risk/reward is weaker than SMCI because the China-policy linkage is indirect, so size should be half or less of the SMCI position.
• Use upside call spreads rather than outright stock for both SMCI and APP; the probability distribution is headline-driven and prone to reversal, so capped downside matters more than unlimited upside.
• If any official statement emphasizes export-control 'dialogue' without specifics, fade the move by trimming longs within the same session; the market will likely front-run substance that is not yet there.